Indefinite Delivery Contract 36C26325D0022

Award Date 12/8/24
Last Date to Order 9/30/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award Indefinite Delivery Contract (IDC) to Microgenics Corporation, the Clinical Diagnostics Division of Thermo Electron Corporation, to provide drugs of abuse analyzers, reagents, and controls in support of substance abuse testing and treatment programs at VA medical facilities. The $895,686 IDC has a period of performance through December 7, 2024 and does not include any set-aside...
This federal Indefinite Delivery Contract (IDC) was awarded by the Navy Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The $323,566.47 single-award IDC has an ultimate completion date of October 31, 2029 and is for the delivery of DRI Hydrocodone Reagent Kits, 500ML. Microgenics is a key supplier for the Department of Defense Drug Demand Reduction Program, providing a wide range of immunoassay...
The Department of Defense (DoD) has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, an indefinite delivery contract (IDC) worth up to $5,515,434.90 to provide benzodiazepine immunoassay reagent kits and related laboratory supplies in support of the DoD Drug Demand Reduction Program (DDRP). This single-award IDC has a period of performance through April 30, 2028 and does not utilize any set-aside designations. Under this IDC, Microgenics has received numerous...
The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 1 (VISN 1), has awarded a Blanket Purchase Agreement (BPA) to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The BPA, valued at a ceiling of $450,000.00, is for the provision of toxicology reagents and equipment, including immunoassay reagent test kits, drug screening products, and related laboratory supplies to support substance abuse testing and treatment programs at military...
Microgenics Corporation, a division of Thermo Electron Corporation's Clinical Diagnostics business, has been awarded multiple firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) by the Department of the Navy Bureau of Medicine and Surgery. The delivery orders, valued from $4,013 to $34,913.10, are for the provision of DRI-ECSTASY PLUS MDMA/MDA and other reagent kits to support the Bureau's drug testing and identification programs at Navy and Marine Corps medical...
The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc., a global leader in in vitro diagnostics, for bacterial identification and susceptibility testing services. The $2,366,377.51 IDC, awarded on April 1, 2021 without any set-aside designations, has an ultimate completion date of March 31, 2026. Under this contract, Biomerieux will provide its proprietary microbiology analyzers,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 23 (VISN 23) awarded a single-award, $549,984.84 Indefinite Delivery Contract to Biomerieux Inc. for the provision of Vitek 2 and Vitek MS microbiology diagnostic testing supplies. The contract has a 5-year period of performance from October 1, 2023 to September 30, 2024. Under this IDC, the VA VISN 23 will issue firm-fixed-price delivery orders to Biomerieux's Emigration Canyon,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded an Indefinite Delivery Contract to MCI Diagnostic Center LLC to provide urine toxicology testing services. The single award IDV has a potential value of $379,007.47 and a period of performance through June 30, 2021. Under the IDV, VISN 5 issued a $92,547 firm fixed price delivery order to MCI Diagnostic Center for urine toxicology testing to support VA clinical care programs in...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including the GeneXpert testing platform. The single-award IDC, valued up to $1,500,000, is for the procurement of GeneXpert test kits, reagents, and associated maintenance and support services. This IDC enables the VA to continuously acquire Cepheid's molecular diagnostic products and...
  • 36C26325D0022
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs, through its Veterans Integrated Service Network 23 (VISN 23), has awarded an indefinite delivery contract (IDC) to Microgenics Corporation, a manufacturer of clinical diagnostic products, for the supply of toxicology reagents. The $852,120.80 single-award IDC has an ultimate completion date of September 30, 2029 and is not set aside for any particular business category.

Under this IDC, Microgenics has received a $770,593.60 firm-fixed price delivery order contract from VISN 23 to provide FDA-approved CEDIA and DRI drugs of abuse reagents, calibrators, and controls for testing substances like oxycodone, ecstasy, heroin, and hydrocodone. This delivery order, which has an ultimate completion date of September 30, 2025, is likely part of Microgenics' existing IDVs with federal agencies, including a $1.15 million IDC with the Navy Bureau of Medicine and Surgery for MDMA/MDA reagent kits, a $750,435 IDC for DRI opiate reagent test kits, and a $5.5 million IDC for benzodiazepine reagent kits. Microgenics' products are utilized across the Department of Defense and Department of Veterans Affairs healthcare systems to support substance abuse testing and treatment programs.

Generated 1/11/25, 9:05 AM